dash使用_使用Dash和SHAP构建和部署可解释的AI仪表盘

dash使用

In recent years, we have seen an explosion in the usage of Machine Learning (ML) algorithms for automating and supporting human decisions. From helping doctors in diagnosing potential diseases that could render diabetic patients blind, to supporting financial analysts in equity management, the impact of ML is irrefutable. However, as algorithms become more sophisticated, it becomes harder to understand how it makes decisions. As a result, various harmful biases could arise in critical situations, such as when ML is used to determine credit limit for credit cards or applied to facial recognition by law enforcement agencies. In order to identify and mitigate the effect of such biases before the model is deployed, it is important to leverage explainable AI (xAI) to better understand which features and factors have the most impact on the final output of the model. This information can then be utilized to help AI developers understand why a certain model might not be performing well in certain scenarios, or just in general. At the same time, such techniques could help us uncover more insights about a problem than simply using black-box models. Ultimately, such techniques can help both technical and non-technical stakeholders better understand and appreciate AI models.

近年来，我们看到了用于自动执行和支持人工决策的机器学习(ML)算法的爆炸式增长。 从帮助医生诊断可能使糖尿病患者失明的潜在疾病 ，到在股权管理方面为财务分析师提供支持 ，ML的影响是无可辩驳的。 但是，随着算法变得越来越复杂，变得越来越难以理解它如何做出决策。 结果，在紧急情况下可能会出现各种有害的偏见，例如当使用ML确定信用卡的信用额度或由执法机构将其应用于面部识别时 。 为了在部署模型之前识别并减轻此类偏差的影响，重要的是利用可解释的AI(xAI)更好地了解哪些特征和因素对模型的最终输出影响最大。 然后，可以利用此信息来帮助AI开发人员理解为什么某些模型在某些情况下或只是在一般情况下表现不佳。 同时，这些技术可以帮助我们发现更多关于问题的见解，而不仅仅是使用黑匣子模型。 最终，此类技术可以帮助技术和非技术利益相关者更好地理解和欣赏AI模型。

用Shapley值解释黑匣子模型 (Explaining black-box models with Shapley Values)

Many researchers and software developers have been working on the subject of explainable AI systems for many years. One approach, which is called SHapley Additive exPlanations (SHAP), has been increasingly popular in the past few years. It has been used to identify chronic kidney disease, to model US mortality factors and to help